Elysium Therapeutics has completed a $7.5 million funding round to accelerate development of its opioid overdose reversal technology. Named SOOPR (Synthetic Opioid Overdose Protection and Reversal), it is designed specifically as a rescue treatment for synthetic opioid overdoses. Namely, this includes fentanyl, but also the emerging threat of more potent nitazenes, according to Elysium. In stating its mission, Elysium says it is a biopharmaceutical company developing treatments to prevent and...